EIT Pathogena

EIT Pathogena is a cutting-edge genomic analysis platform for academics and public health professionals around the world to help fight infectious diseases.

The new EIT Oxford Campus, designed by Lord Norman Foster. Due to be completed in 2027

EIT new building

Our History

EIT Pathogena originated as Global Pathogen Analysis Service (GPAS) Ltd. Established in September 2021 during the global COVID-19 pandemic, GPAS distributed the SARS-CoV-2 bioinformatics pipeline developed by the Modernising Medical Microbiology (MMM) unit at the University of Oxford led by Professor Derrick Crook.
Following the end of the pandemic, the MMM group has pivoted back to developing a bioinformatics pipeline for Mycobacteria, building on the work of the CRyPTIC Project.

Since its inception, GPAS Ltd has been funded by Larry Ellison, founder and CTO of Oracle Inc, with the objective of building a genomic pathogen analysis platform that supports clinical decisions and public health surveillance to improve global health.

Joining EIT Oxford

In June 2024, GPAS joined the Ellison Institute of Technology Oxford, as the foundation for a new Pathogen Programme in Health and Medical Science.

EIT Oxford is a major new interdisciplinary research and development facility that translates scientific research and discovery into end-to-end solutions to solve the world’s most enduring challenges.

Guided by our President, Professor Sir John Bell, alongside world leaders, scientists, and entrepreneurs, EIT works in four areas of scientific and technological innovation: health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation in the era of artificial intelligence.

Specifically, our health & medical science area seeks to:

  • Improve the quality and lower the cost of healthcare worldwide.

  • Use generative artificial intelligence to accelerate innovation.

  • Use digital cloud infrastructure to equitably distribute lifesaving vaccines, therapeutics, and technologies globally.

It's the beginning of a new era, marked by cutting-edge research, innovation, and collaboration.

The EIT Oxford Campus will have interdisciplinary collaborative work spaces, bringing together scientists, researchers, AI and policy experts and technologists.

Overhead shot of buildings

Our Vision

Lab workers
Lab workers

The Tissue Culture Lab is part of the cutting-edge facilities at the new EIT Oxford Campus which bridges the Oxford Science Park and Littlemore.

Lab workers at their desks
We are on a journey - Always On. Our long-term vision is to co-develop a global, ‘always-on’ strategic point-of-care diagnostics and surveillance system to improve the treatment of infectious diseases, fight antimicrobial resistance and transform outbreak response.

Transformational innovation within sample preparation and sequencing technologies will speed the movement of genomic testing from remote central labs to a ‘sequencing first’ approach from clinicians at routine points of care.

We are dedicated to pushing the boundaries of what's possible in pathogen analysis and global health improvement. We will save lives avoidably lost to infectious diseases through our simple ethos – authentic collaboration.

What's Important to Us

Collaborations among clinicians, researchers, academics, and governments worldwide are at the heart of everything we do. Through these authentic partnerships, we harness diverse expertise and resources to tackle global health challenges more effectively.

By working together, we can accelerate the development and equitable distribution of innovative solutions, ensuring that our vision becomes a reality in the shortest possible time.

These partnerships enable sharing knowledge, leveraging advanced technologies, and implementing best practices across different regions, ultimately enhancing our ability to respond to public health threats swiftly and efficiently.

Collaborate with us
What's Important to Us graph
Professor Derrick Crook

Professor Derrick Crook

EIT Pathogena FounderUniversity of Oxford
“As we launch EIT Pathogena, we are not only expanding our research capabilities but also our ability to make a real-world impact. With leadership from experts and the dedication of our teams, we are committed to enhancing and improving infectious disease management across the world."